Caring for Patients in Today's Opioid Landscape

In 2021, overdose deaths in the United States reached a record high. At the same time, restrictions on prescription opioids strand many patients without adequate care. For policymakers and providers, ensuring quality patient care and reducing harm requires navigating an evolving landscape of restrictions and best practices. The New York State Department of Health Commissioner’s Grand Round will convene subject-matter experts to discuss New York State’s response to the opioid crisis and harm reduction strategies; the importance of using a health equity lens in the treatment of opioid use disorder (OUD); and guidance for treating chronic pain with opioids.

How to watch this webcast

Session details:

Moderator

  • Mary T. Bassett, MD, MPH, Commissioner of the New York State Department of Health

Opening Remarks

  • Mary P. Gallant, PhD, MPH, Interim Dean, University at Albany School of Public Health

Speakers

  • Chinazo Cunningham, MD, Commissioner, New York Office of Addiction Services and Supports
    Presentation (PDF)
  • Ayana Jordan, MD, PhD, Associate Professor, NYU Grossman School of Medicine Department of Psychiatry and Department of Population Health
    Presentation (PDF)
  • Joanna Starrels, MD, MS, Professor of Medicine, Psychiatry & Behavioral Science, Albert Einstein College of Medicine and Montefiore Medical Center Associate Chief of the Division of General Internal Medicine, Albert Einstein College of Medicine and Montefiore Medical Center
    Presentation (PDF)

Continuing Education Credits

  • Learning Outcome: As a result of participation in this Grand Round, learners will increase and enhance their knowledge and competence to equitably treat chronic pain and/or substance use disorder amidst the opioid landscape in New York State.
  • CME, CNE, CHES and CPH credits are available for the Live webcast on November 17, 2022 and for the recorded enduring activity through November 30, 2023.
  • Criteria for Successful Completion: Learners must attend 100% of this activity to be awarded full continuing education credits /contact hours.
  • Continuing Medical Education Credits:
    • The School of Public Health, University at Albany is accredited by the Medical Society of the State of New York (MSSNY) to provide continuing medical education for physicians.
    • The School of Public Health, University at Albany designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • Continuing Nursing Education Contact Hours:
    • University at Albany School of Public Health is approved with distinction as a provider of nursing continuing professional development by the Northeast Multistate Division Education Unit, an accredited approver by the American Nurses Credentialing Center's Commission on Accreditation. This offering is approved for _2.0_ nursing contact hour.
  • Certified Health Education Specialist Contact Hours:
    • Sponsored by the School of Public Health, University at Albany, SUNY, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 2.0 total Category I contact education contact hours. Maximum advanced-level continuing education contact hours available are 0. Continuing Competency credits available are 2.0. Provider ID# 99086.
  • Certified in Public Health:
    • This event is sponsored by School of Public Health, University at Albany, an approved provider of CPH Renewal Credits by the National Board of Public Health Examiners. This offering is approved for 2.0 Certified in Public Health Renewal Credits.

Disclosure Statements

Joanna L. Starrels, MD, MS has disclosed she is a site PI for an FDA-mandated, multi-site observational study of the risks of prescription opioids, through a sub-contract with the Clinical Directors' Network and the Opioid Post-marketing Requirement Consortium.

All relevant financial relationships have been mitigated.

None of the other planners, moderator, and presenters have any financial arrangements or affiliations with any ineligible companies whose products, research or services may be discussed in this activity.

No commercial funding has been accepted for this activity.